Trials / Completed
CompletedNCT00564330
In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole
In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Brain-Gut Research Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks. The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition. Secondary objectives are: To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth. To assess sex differences in OCT- quantified dental tissue loss.
Detailed description
Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks. The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition. Secondary objectives are: To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth. To assess sex differences in OCT- quantified dental tissue loss
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | 20mg bid |
| DRUG | Placebo | Placebo bid |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-04-01
- Completion
- 2008-05-01
- First posted
- 2007-11-27
- Last updated
- 2014-08-26
Source: ClinicalTrials.gov record NCT00564330. Inclusion in this directory is not an endorsement.